Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
This transition is explored in “Embodied Artificial Intelligence in Healthcare: A Systematic Review of Robotic Perception, ...
A new academic review argues that artificial intelligence (AI) could help cities dim the lights intelligently, cutting both energy consumption and light pollution without compromising visibility or ...
Patient digital twins aim to create computational replicas of an individual’s physiology that can predict disease trajectories and treatment response.
Artificial intelligence (AI) has become an indispensable tool in Estonian hospitals, aiding both stroke and radiation therapy treatment while saving doctors hours of valuable time. At the same time, ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a research collaboration with University Hospital Essen on the PROMISE-PET registry 1, defining the potential prognostic ...
AI integration in employer-sponsored health care is accelerating. Here are 5 key opportunities to drive better quality, ...
Chief Executive Officer and co-founder Ben Zeskind told attendees at Oppenheimer’s 36th Annual Healthcare Life Sciences ...
Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative ...
The intersection of artificial intelligence and mechanistic neuroscience is rapidly transforming our understanding of neural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results